Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease

Y. Mazor, R. Almog, U. Kopylov, D. Ben Hur, A. Blatt, A. Dahan, M. Waterman, S. Ben-Horin, Y. Chowers

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences